Not eating enough protein or fibre Protein and fibre are the two most powerful nutrients for satiety
Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
As previously mentioned, early studies using direct measurements in muscle after 14 days on 4 to 6 g of carnitine per day failed to show increases in the muscle carnitine concentration (4, 5)
This decrease has been associated with many common symptoms people notice over time, such as: Persistent fatigue Slower recovery after exercise Brain fog Reduced metabolic efficiency While aging is natural, supporting cellular energy production may help maintain vitality and resilience as the years go on
However, although the solution is simple, it is by no means easy
doi: 10.1002/jlb.54.2.119
